Key Market Indicator:
F&G: 21
24.927,00 NASDAQ · 46.487,50 DOW · 6.749,65 S&P · 4.011,22 Gold · 63,89 BRENT

One Community. One Spirit. N#1 Broker.
all asset classes · all possibilities

Switch View
Hedge the Peak | Protect your Profits
© ACCESSWIRE
05.09.2025
ISIN: US03476V1008
Angle plc
ANPCY
LISTED
OTC
Angle PLC Announces Notice of Results
Article
News Preview
ANGLE plc ("the Company") Notice of Interim Results and Webcast GUILDFORD, SURREY / ACCESS Newswire / September 5, 2025 / ANGLE plc (AIM:AGL)(OTCQX:ANPCY), a world-leading liquid biopsy company with innovative circulating tumour cell (CTC) diagnostic solutions for use in research, drug development and clinical oncology, will be releasing...
Themefolio
Profiler
Peergroup
© Globe Newswire
05.09.2025
ISIN: US09075X1081
Biodesix Inc
BDSX
LISTED
NASDAQ
Biodesix to Participate in Lake Street Capital Markets’ 9th Annual Best Ideas Growth (BIG9) Conference
Article
News Preview
LOUISVILLE, Colo., Sept. 05, 2025 (GLOBE NEWSWIRE) -- Biodesix, Inc. (Nasdaq: BDSX), a leading diagnostic solutions company, today announced Robin Cowie, Chief Financial Officer, will host in-person 1x1 investor meetings at Lake Street Capital Markets’ 9th Annual Best Ideas Growth (BIG9) Conference on Thursday, September 11, 2025....
Themefolio
Profiler
Peergroup
© ACCESSWIRE
05.09.2025
ISIN: US5845073056
Medical Care Technologies Inc.
MDCE
LISTED
OTC
Medical Care Technologies Inc. (OTC PINK:MDCE) Unveils AI Age-Based Health Risk Estimator Targeting $1 Trillion Digital Health Market by 2030
Article
News Preview
MESA, ARIZONA / ACCESS Newswire / September 5, 2025 / Medical Care Technologies Inc. (OTC PINK:MDCE) today unveiled its AI Facial Age-Based Health Risk Estimator, a breakthrough technology that uses facial imaging to deliver predictive health insights.The system leverages micro-wrinkle density, skin elasticity, and tonal gradient analysis to genera...
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
More Info
Knowing what matters
Short sale statistics, hedge fund activities and much more user-friendly information
© Globe Newswire
05.09.2025
ISIN: US0352551081
Anika Therapeutics Inc
ANIK
LISTED
NASDAQ
Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Article
News Preview
BEDFORD, Mass., Sept. 05, 2025 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global leader in the osteoarthritis pain management and regenerative solutions spaces focused on early intervention orthopedics, today announced that on September 2, 2025, Anika granted non-statutory stock options (“Options”) covering an aggregate of 2,5...
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© ACCESSWIRE
05.09.2025
ISIN: US47010C4096
Jaguar Health, Inc.
JAGX
LISTED
NASDAQ
Jaguar Health Presenting at September 8-10 H.C. Wainwright Annual Global Investment Conference to Provide Updates on Near-Term Catalysts
Article
News Preview
Click here to register SAN FRANCISCO, CALIFORNIA / ACCESS Newswire / September 5, 2025 / Jaguar Health, Inc. (NASDAQ:JAGX) today announced that Lisa Conte, the company's founder, president and CEO, will present virtually at the H.C. Wainwright 27th Annual Global Investment Conference, which takes place September 8-10, 2025.Participation Instruction...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
05.09.2025
ISIN: CA68237C1059
Onco-Innovations Limited
ONCO
LISTED
CSE
Onco-Innovations Appoints Dr. John Mackey to Scientific & Clinical Advisory Board
Article
News Preview
VANCOUVER, BC / ACCESS Newswire / September 5, 2025 / Onco-Innovations Limited (CBOE CA:ONCO)(Frankfurt:W1H)(WKN:A3EKSZ) ("Onco" or the "Company") is pleased to announce the appointment of Dr. John Mackey, Professor Emeritus in the Department of Oncology at the University of Alberta, to its Scientific and Clinical Advisory Board...
Themefolio
Profiler
Peergroup
© BusinessWire
05.09.2025
ISIN: US69120X2062
Owlet Inc
OWLT
LISTED
NYSE
Owlet Extends Global Reach with Launch of Medically-Certified Dream Sock™ to South Africa
Article
News Preview
Owlet, Inc. (“Owlet” or the “Company”) (NYSE: OWLT), the pioneer of smart infant monitoring, announces the launch of medically-certified Dream Sock™ in South Africa. Distributed as a Class C Medical Device with CE Marking, this groundbreaking product enables parents to track Baby’s live vital signs and receive real-time health notifications, deliv...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
05.09.2025
ISIN: US9495031067
Wellgistics Health, Inc.
WGRX
LISTED
NASDAQ
Wellgistics Health, Inc. to Present at September Investor Conferences
Article
News Preview
TAMPA, FL / ACCESS Newswire / September 5, 2025 / Wellgistics Health, Inc. (NASDAQ:WGRX) ("Wellgistics Health" or the "Company"), a leader in next-generation pharmaceutical distribution, digital prescription routing, and AI-powered hub fulfillment, today announced that Brian Norton, Chief Executive Officer, together with members...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
05.09.2025
ISIN: CA0717341071
Bausch Health Companies Inc
BHC
LISTED
TSX
Bausch Health's Aesthetic Business, Solta Medical, Surpasses Milestone of 5 Million Skin Tightening Treatments with Thermage(R) Non-Surgical System
Article
News Preview
LAVAL, QC / ACCESS Newswire / September 5, 2025 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC), a global, diversified pharmaceutical company, and Solta Medical, a global leader in the medical aesthetics market, today announced that the Company's proven Thermage technology has successfully been used to perform more than 5 million skin tightening...
Themefolio
Profiler
Peergroup
© Globe Newswire
05.09.2025
ISIN: SE0006219176
Arcoma AB
ARCOMA
LISTED
STO
Arcoma AB inför incitamentsprogram kopplat till aktieköp för ledning och andra ledande befattningshavare i företaget. 
Article
News Preview
PRESSRELEASE...
Themefolio
Profiler
Peergroup
© Globe Newswire
05.09.2025
ISIN: DK0015998017
Bavarian Nordic A/S
BAVA
LISTED
CPH
Capital Increase in Bavarian Nordic A/S as a Result of Employee Warrant Exercise
Article
News Preview
COPENHAGEN, Denmark, September 5, 2025 – Bavarian Nordic A/S (OMX: BAVA) announced today that the Company's share capital has been increased by nominally DKK 3,818,710 as a consequence of employees’ exercise of warrants....
Themefolio
Profiler
Peergroup
© EQS Newswire
05.09.2025
ISIN: CH1330780979
Curatis Holding AG
CURN
LISTED
SIX
Curatis expands distribution business with Phoenix Labs with up to CHF 5m additional annual revenues
Article
News Preview
Curatis Holding AG / Key word(s): Agreement/Incoming Orders Curatis expands distribution business with Phoenix Labs with up to CHF 5m additional annual revenues 05.09.2025 / 07:00 CET/CEST MEDIA RELEASE Liestal, Switzerland, 5 September 2025: Curatis Holding AG (SIX: CURN, 'Curatis') announces a new distribution contrac......
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© EQS Newswire
05.09.2025
ISIN: IT0004147952
Newron Pharmaceuticals SpA
NWRN
LISTED
SIX
Newron to present data and updates on its clinical program evaluating evenamide as an add-on treatment for schizophrenia at the 2025 World Congress of Biological Psychiatry (WCBP)
Article
News Preview
Newron to present data and updates on its clinical program evaluating evenamide as an add-on treatment for schizophrenia at the 2025 World Congress of Biological Psychiatry (WCBP) The importance of glutamate release modulation by evenamide used as an add-on therapy for patients with schizophrenia inadequately responding to their second-generati......
Themefolio
Profiler
Peergroup
© EQS Newswire
05.09.2025
ISIN: IT0004147952
Newron Pharmaceuticals SpA
NWRN
LISTED
SIX
Newron präsentiert Daten und Updates zu seinem klinischen Programm zur Entwicklung von Evenamide als Zusatztherapie bei Schizophrenie auf dem Weltkongress für Biologische Psychiatrie (WCBP) 2025
Article
News Preview
Newron präsentiert Daten und Updates zu seinem klinischen Programm zur Entwicklung von Evenamide als Zusatztherapie bei Schizophrenie auf dem Weltkongress für Biologische Psychiatrie (WCBP) 2025 Die Bedeutung der Modulation der Glutamat-Freisetzung durch Evenamide als Zusatztherapie für Patienten mit Schizophrenie, die unzureichend auf Antipsychot......
Themefolio
Profiler
Peergroup
© BusinessWire
05.09.2025
ISIN: CH1330780979
Curatis Holding AG
CURN
LISTED
SIX
Curatis Expands Distribution Business With Phoenix Labs with up to CHF 5m Additional Annual Revenues
Article
News Preview
Curatis Holding AG (SIX: CURN, 'Curatis') announces a new distribution contract with Phoenix Labs (Ireland) for four products in Switzerland. Significant revenue growth with new products Curatis has signed a contract with Phoenix Labs (Ireland) to distribute four products in the areas of pain management and urology in Switzerland, starting fro...
Themefolio
Profiler
Peergroup
© Globe Newswire
05.09.2025
ISIN: DK0062498333
Novo Nordisk A/S
NOVO B
LISTED
CPH
Novo Nordisk to present new semaglutide data on ‘food noise’, body composition and cardiovascular benefits, as well as pipeline data at the EASD diabetes congress
Article
News Preview
Bagsværd, Denmark, 5 September 2025 – Novo Nordisk today announced the presentation of 35 abstracts from across its diabetes and obesity portfolio at the upcoming European Association for the Study of Diabetes (EASD) congress 2025 from 15 to 19 September in Vienna, Austria. The presentations include clinical and real-world data reinforcing semaglut...
Themefolio
Profiler
Peergroup
© Globe Newswire
05.09.2025
ISIN: CH0363463438
Idorsia Ltd
IDIA
LISTED
SIX
Idorsia to collaborate with two leading academic medical centers to launch IMPACT-HTN – a US initiative to transform care for patients with difficult-to-control hypertension
Article
News Preview
Allschwil, Switzerland & Radnor, Philadelphia – September 5, 2025Idorsia Ltd (SIX: IDIA) announces a first-of-its-kind initiative with the Stanford Hypertension Center and Duke Heart Center to launch IMPACT-HTN, a new three-phase program to transform and modernize the management of difficult-to-control hypertension. Patients requiring multiple...
Themefolio
Profiler
Peergroup
© Globe Newswire
05.09.2025
ISIN: CH0012032048
Roche Holding AG
ROG
LISTED
SIX
New data for Roche's Vabysmo reinforce its efficacy, safety and durability in neovascular or “wet” age-related macular degeneration (nAMD)
Article
News Preview
Basel, 05 September 2025 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today new data from the AVONELLE-X and SALWEEN studies of Vabysmo® (faricimab),1,2 presented at the 25th Euretina Congress in Paris, France. Data from the open-label AVONELLE-X study reinforce the efficacy, safety and durability of Vabysmo over four years in neovascular or “wet...
Themefolio
Profiler
Peergroup
© Newsfile
05.09.2025
ISIN: CA12675Q1019
C21 Investments Inc.
CXXI
LISTED
CSE
C21 Investments Announces Settlement of Eco Firma Farms Litigation
Article
News Preview
Vancouver, British Columbia--(Newsfile Corp. - September 4, 2025) - C21 Investments Inc. (CSE: CXXI) (OTCQX: CXXIF) ("C21" or the "Company"), a vertically integrated cannabis company, today announced it has entered into a settlement agreement (the "Settlement Agreement") with respect to certain actions filed in the Oregon State Circuit Court for Cl...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
05.09.2025
ISIN: CA0909741062
BioNxt Solutions Inc.
BNXT
LISTED
CSE
BioNxt Solutions Completes Up-Listing to The OTCQB Market
Article
News Preview
VANCOUVER, BC / ACCESS Newswire / September 5, 2025 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTCQB:BNXTF)(FSE:4XT), is pleased to announce that the common shares of the Company (the "Common Shares") shall commence trading on the OTCQB market under the ticker symbol "BNXTF" as of Septembe...
Themefolio
Profiler
Peergroup
© PR Newswire
05.09.2025
ISIN: US67079U3068
Nutex Health Inc
NUTX
LISTED
NASDAQ
Nutex Health (NUTX) Securities Suit Alleges Fraud and Financial Misstatements-- Hagens Berman
Article
News Preview
NUTX Investors with Losses Encouraged to Contact Hagens Berman SAN FRANCISCO, Sept. 4, 2025 /PRNewswire/ -- A new class-action lawsuit alleges that Nutex Health, Inc. (NASDAQ: NUTX), a hospital and healthcare services company, engaged in a fraudulent scheme with a third-party billing firm to inflate its revenues, leading to millions of dollars in...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
05.09.2025
ISIN: GB00BYX3WZ24
Hemogenyx Pharmaceuticals plc
HEMO
LISTED
LSE
Hemogenyx Pharmaceuticals PLC Announces Exercise of Warrants and Issue of Equity
Article
News Preview
THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS STIPULATED UNDER THE UK VERSION OF THE MARKET ABUSE REGULATION NO 596/2014 WHICH IS PART OF ENGLISH LAW BY VIRTUE OF THE EUROPEAN (WITHDRAWAL) ACT 2018, AS AMENDED. ON PUBLICATION OF THIS ANNOUNCEMENT VIA A REGULATORY INFORMATION SERVICE, THIS INFORMATION IS CONSIDERED TO BE IN THE PUBLIC DOMAIN. LON...
Themefolio
Profiler
Peergroup
© PR Newswire
05.09.2025
ISIN: CA10919W4056
Bright Minds Biosciences Inc.
DRUG
LISTED
NASDAQ
BRIGHT MINDS BIOSCIENCES ANNOUNCES AT-THE-MARKET OFFERING
Article
News Preview
VANCOUVER, BC, Sept. 4, 2025 /CNW/ - Bright Minds Biosciences Inc. (CSE: DRUG) (NASDAQ: DRUG) ("Bright Minds" or the "Company") announces that it has entered into an equity distribution agreement (the "Equity Distribution Agreement") providing for an at-the-market equity offering program ("ATM") with Piper Sandler & Co. and Cantor Fitzgerald...
Themefolio
Profiler
Peergroup
© Globe Newswire
05.09.2025
ISIN: KYG4672N1198
HUTCHMED (China) Ltd
13
LISTED
HKSE
HUTCHMED Highlights Clinical Data to be Presented at the 2025 World Conference of Lung Cancer and the CSCO Annual Meeting 2025
Article
News Preview
HONG KONG and SHANGHAI and FLORHAM PARK, N.J., Sept. 05, 2025 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM:​HCM; HKEX:​13) today announces that new and updated data from several studies of compounds discovered by HUTCHMED will be presented at the 2025 World Conference on Lung Cancer (“WCLC”) taking place on September 6-9,...
Themefolio
Profiler
Peergroup
© BusinessWire
04.09.2025
ISIN: US74587V1070
Puma Biotechnology Inc
PBYI
LISTED
NASDAQ
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
Article
News Preview
Puma Biotechnology, Inc. (Nasdaq: PBYI), a biopharmaceutical company, announced that on September 2, 2025, the Compensation Committee of Puma’s Board of Directors approved the grant of inducement restricted stock unit awards covering 25,750 shares of Puma common stock to four new non-executive employees. The awards were granted under Puma’s 2017...
Themefolio
Profiler
Peergroup
© BusinessWire
04.09.2025
ISIN: US45257U1088
Immunome Inc
IMNM
LISTED
NASDAQ
Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Article
News Preview
Immunome, Inc. (the “Company”) (Nasdaq: IMNM), a biotechnology company focused on developing first-in-class and best-in-class targeted cancer therapies, announced today that on Sept. 2, 2025, the Compensation Committee of the Company’s Board of Directors (the “Compensation Committee”) granted inducement awards consisting of non-statutory stock opt...
Themefolio
Profiler
Peergroup
© Globe Newswire
04.09.2025
ISIN: US62855J1043
Myriad Genetics Inc
MYGN
LISTED
NASDAQ
Myriad Genetics Announces Precise MRD Clinical Data Published in The Lancet Oncology
Article
News Preview
SALT LAKE CITY, Sept. 04, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, today announced The Lancet Oncology published a study highlighting the performance of Myriad’s molecular residual disease (MRD) test, Precise® MRD, in patients with oligometastatic clear-cell r...
Themefolio
Profiler
Peergroup
© PR Newswire
04.09.2025
ISIN: US29261A1007
Encompass Health Corp
EHC
LISTED
NYSE
Rosen Law Firm Encourages Encompass Health Corporation Investors to Inquire About Securities Class Action Investigation - EHC
Article
News Preview
NEW YORK, Sept. 4, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Encompass Health Corporation (NYSE: EHC) resulti...
Themefolio
Profiler
Peergroup
© BusinessWire
04.09.2025
ISIN: US71944F1066
Phreesia, Inc.
PHR
LISTED
NYSE
Phreesia Announces Second Quarter Fiscal 2026 Results
Article
News Preview
Phreesia, Inc. (NYSE: PHR) (“Phreesia” or the "Company") announced financial results today for the fiscal second quarter ended July 31, 2025. “I am proud to share that Phreesia has had many noteworthy developments over the past quarter. In addition to delivering another solid set of financial results, including achieving our first-ever net incom...
Themefolio
Profiler
Peergroup
© PR Newswire
04.09.2025
ISIN: US98956P1021
Zimmer Biomet Holdings Inc
ZBH
LISTED
NYSE
Zimmer Biomet to Showcase Foot and Ankle Portfolio at the American Orthopedic Foot and Ankle Society Annual Conference
Article
News Preview
WARSAW, Ind., Sept. 4, 2025 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced its participation in the American Orthopedic Foot and Ankle Society Annual Conference in Savannah, Ga. From September 10-13, 2025, Zimmer Biomet's wholly owned subsidiary, Paragon 28, will feature a sui...
Themefolio
Profiler
Peergroup
© BusinessWire
04.09.2025
ISIN: US71944F1066
Phreesia, Inc.
PHR
LISTED
NYSE
Phreesia to Acquire AccessOne, Expanding Its Suite of Payment Solutions
Article
News Preview
Phreesia, Inc. (NYSE: PHR) (“Phreesia”), a trusted leader in patient activation, today announced it has entered into a definitive agreement to acquire AccessOne Parent Holdings, Inc. (together with its subsidiaries, “AccessOne”), a portfolio company of Frontier Growth, for aggregate consideration of $160 million in cash (the “AccessOne Acquisition...
Themefolio
Profiler
Peergroup
© PR Newswire
04.09.2025
ISIN: US0311621009
Amgen Inc
AMGN
LISTED
NASDAQ
AMGEN TO PRESENT AT THE MORGAN STANLEY 23RD ANNUAL GLOBAL HEALTHCARE CONFERENCE
Article
News Preview
THOUSAND OAKS, Calif., Sept. 4, 2025 /PRNewswire/ -- Amgen (NASDAQ:AMGN) will present at the Morgan Stanley 23rd Annual Global Healthcare Conference at 9:15 a.m. ET on September 9, 2025. Peter Griffith, executive vice president and chief financial officer at Amgen, and Kave Niksefat, senior vice president of Global Marketing and Access at Amgen,...
Themefolio
Profiler
Peergroup
© Newsfile
04.09.2025
ISIN: CA68405U1012
Optimind Pharma Corp.
OMND
LISTED
CSE
Optimind Pharma Announces Termination of Letter of Intent
Article
News Preview
Toronto, Ontario--(Newsfile Corp. - September 4, 2025) - Optimind Pharma Corp. (CSE: OMND) (the "Optimind" or the "Company") announces that its previously announced non-binding letter of intent dated March 18, 2025 with Monjin Interviews Private Limited ("Monjin"), with respect to the Company's acquisition of Monjin, has been mutually terminated by...
Themefolio
Profiler
Peergroup
© Newsfile
04.09.2025
ISIN: CA74141E1043
PreveCeutical Medical Inc.
PREV
LISTED
CSE
PreveCeutical Announces Arrangement Agreement with BioGene Therapeutics
Article
News Preview
Vancouver, British Columbia--(Newsfile Corp. - September 4, 2025) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE:18H) (the "Company" or "PreveCeutical") announces that it has entered into a definitive arrangement agreement (the "Arrangement Agreement") dated September 3, 2025 with its subsidiary, BioGene Therapeutics Inc. ("BioGe...
Themefolio
Profiler
Peergroup
© Globe Newswire
04.09.2025
ISIN: US68572M1062
Orchestra Biomed Holdings Inc
OBIO
LISTED
NASDAQ
Orchestra BioMed Presents New AVIM Therapy Clinical Data at HRX Demonstrating Substantial and Sustained Blood Pressure Reductions that are Reproducible Upon Reactivation Following Washout
Article
News Preview
NEW HOPE, Pa., Sept. 04, 2025 (GLOBE NEWSWIRE) -- Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO, “Orchestra BioMed” or the “Company”), a biomedical company accelerating high-impact technologies to patients through risk-reward sharing partnerships, today announced new data from its AVIM therapy program, presented at the HRX Live 2025 Meeting, in A...
Themefolio
Profiler
Peergroup
© BusinessWire
04.09.2025
ISIN: US3755581036
Gilead Sciences Inc
GILD
LISTED
NASDAQ
Gilead Announces Partnership With PEPFAR to Deliver Twice-Yearly Lenacapavir for HIV Prevention for up to Two Million People in Primarily Low- and Lower-Middle-Income Countries
Article
News Preview
Gilead Sciences, Inc. (Nasdaq: GILD) today announced a partnership with the U.S. State Department and the United States President’s Emergency Plan for AIDS Relief (PEPFAR) to deliver lenacapavir—Gilead's twice-yearly injectable HIV-1 capsid inhibitor—for the prevention of HIV as pre-exposure prophylaxis (PrEP). This is a key component of Gilead’s...
Themefolio
Profiler
Peergroup
© Globe Newswire
04.09.2025
ISIN: US86889P2083
Surrozen, Inc.
SRZN
LISTED
NASDAQ
Surrozen Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Article
News Preview
Surrozen Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)...
Themefolio
Profiler
Peergroup
© Globe Newswire
04.09.2025
ISIN: GB00BMVP7Y09
Royalty Pharma PLC
RPRX
LISTED
NASDAQ
Royalty Pharma to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference
Article
News Preview
NEW YORK, Sept. 04, 2025 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced that it will participate in a fireside chat at the Morgan Stanley 23rd Annual Global Healthcare Conference on Tuesday, September 9, 2025 at 3:20 p.m. ET....
Themefolio
Profiler
Peergroup
© Globe Newswire
04.09.2025
ISIN: US5147661046
Lifecore Biomedical Inc
LFCR
LISTED
NASDAQ
Lifecore Biomedical to Participate at 24th Annual Contract Pharma Contracting and Outsourcing Conference
Article
News Preview
CHASKA, Minn., Sept. 04, 2025 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated contract development and manufacturing organization (“CDMO”), today announced that the company will participate at the 24th Annual Contract Pharma Contracting and Outsourcing Conference. Recognized as one of the top annual e...
Themefolio
Profiler
Peergroup
© Globe Newswire
04.09.2025
ISIN: US5588681057
Madrigal Pharmaceuticals Inc
MDGL
LISTED
NASDAQ
Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)
Article
News Preview
CONSHOHOCKEN, Pa., Sept. 04, 2025 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL), a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), today announced that it granted equity awards on September 1, 2025 to 17 new non-executive employees as equity inducem...
Themefolio
Profiler
Peergroup
© Globe Newswire
04.09.2025
ISIN: US75886F1075
Regeneron Pharmaceuticals Inc
REGN
LISTED
NASDAQ
Regeneron Announces Updated Presentation Time for Upcoming Investor Conference
Article
News Preview
TARRYTOWN, N.Y., Sept. 04, 2025 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) announced today that it will now present at the Morgan Stanley 23rd Annual Global Healthcare Conference at 7:00 a.m. ET on Monday, September 8, 2025....
Themefolio
Profiler
Peergroup
© Globe Newswire
04.09.2025
ISIN: US03168L1052
Amneal Pharmaceuticals Inc
AMRX
LISTED
NASDAQ
Amneal Receives U.S. FDA Approval for Risperidone Extended-Release Injectable Suspension
Article
News Preview
BRIDGEWATER, N.J., Sept. 04, 2025 (GLOBE NEWSWIRE) -- Amneal Pharmaceuticals, Inc. (“Amneal” or the “Company”) today announced the U.S. Food and Drug Administration (FDA) approval of risperidone extended-release injectable suspension 12.5 mg/vial, 25 mg/vial, 37.5 mg/vial and 50 mg/vial, which references Janssen’s Risperdal Consta®. The product i...
Themefolio
Profiler
Peergroup
© Globe Newswire
04.09.2025
ISIN: US6031701013
Mineralys Therapeutics Inc
MLYS
LISTED
NASDAQ
Mineralys Therapeutics Announces Closing of Upsized $287.5 Million Underwritten Public Offering of Common Stock Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
Article
News Preview
RADNOR, Pa., Sept. 04, 2025 (GLOBE NEWSWIRE) -- Mineralys Therapeutics, Inc. (Nasdaq: MLYS), a clinical-stage biopharmaceutical company focused on developing medicines to target hypertension and related comorbidities such as chronic kidney disease (CKD), obstructive sleep apnea (OSA) and other diseases driven by dysregulated aldosterone, announce...
Themefolio
Profiler
Peergroup
© Globe Newswire
04.09.2025
ISIN: US45339J1051
Indaptus Therapeutics, Inc.
INDP
LISTED
NASDAQ
Indaptus Therapeutics Provides Clinical Update
Article
News Preview
Decoy20 monotherapy induces Partial Response in patient with urothelial cancer and liver metastases...
Themefolio
Profiler
Peergroup
© Globe Newswire
04.09.2025
ISIN: US74006W1080
Praxis Precision Medicines Inc
PRAX
LISTED
NASDAQ
Praxis Precision Medicines to Participate in September Investor Conferences
Article
News Preview
BOSTON, Mass., Sept. 04, 2025 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system (CNS) disorders characterized by neuronal excitation-inhibition imbalance, today announced that Praxis’ management w...
Themefolio
Profiler
Peergroup
© Newsfile
04.09.2025
ISIN: CA98402E2069
Xebra Brands
XBRA
LISTED
CSE
CSE Bulletin: Suspension - XEBRA Brands Ltd. (XBRA)
Article
News Preview
Toronto, Ontario--(Newsfile Corp. - Le 4 septembre/September 2025) - Effective immediately, XEBRA Brands Ltd. is suspended pursuant to CSE Policy 3. The suspension is considered a Regulatory Halt as defined in National Instrument 23-101 Trading Rules. A cease trade order has been issued by the British Columbia Securities Commission....
Themefolio
Profiler
Peergroup
© BusinessWire
04.09.2025
ISIN: US76029N1063
Replimune Group Inc
REPL
LISTED
NASDAQ
Replimune Group, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - REPL
Article
News Preview
The DJS Law Group reminds investors of a class action lawsuit against Replimune Group, Inc. (“Replimune” or “the Company”) (NASDAQ: REPL) violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Shareholders who purchased shares of REPL during the...
Themefolio
Profiler
Peergroup
© BusinessWire
04.09.2025
ISIN: US1255231003
Cigna Group (The)
CI
LISTED
NYSE
AM Best Assigns Issue Credit Ratings and Indicative Issue Credit Ratings to The Cigna Group
Article
News Preview
AM Best has assigned a Long-Term Issue Credit Rating (Long-Term IRs) of “bbb+” (Good) to The Cigna Group’s (Cigna) (headquartered in Bloomfield, CT) [NYSE: CI] new senior unsecured notes. In addition, AM Best has assigned indicative Long-Term IRs on the recently filed shelf registration of Cigna. The outlook assigned to these Credit Ratings (ratin...
Themefolio
Profiler
Peergroup
© BusinessWire
04.09.2025
ISIN: US78349D1072
Rxsight Inc
RXST
LISTED
NASDAQ
RxSight, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - RXST
Article
News Preview
The DJS Law Group reminds investors of a class action lawsuit against RxSight, Inc. (“RxSight” or “the Company”) (NASDAQ: RXST) violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Shareholders who purchased shares of RXST during the class per...
Themefolio
Profiler
Peergroup
© BusinessWire
04.09.2025
ISIN: US6404911066
Neogen Corp
NEOG
LISTED
NASDAQ
Neogen Corporation Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - NEOG
Article
News Preview
The DJS Law Group reminds investors of a class action lawsuit against Neogen Corporation (“Neogen” or “the Company”) (NASDAQ: NEOG) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Shareholders who purchased shares of NEOG during the c...
Themefolio
Profiler
Peergroup
© PR Newswire
04.09.2025
ISIN: IE00BTN1Y115
Medtronic PLC
MDT
LISTED
NYSE
Study of Medtronic Hugo™ robotic-assisted surgery system in hernia repair meets safety and effectiveness endpoints
Article
News Preview
First-ever investigational device exemption clinical study for robotic-assisted hernia repair in the U.S. presented at the American Hernia Society annual meeting GALWAY, Ireland and NASHVILLE, Tenn., Sept. 4, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT) today announced results from the Enable Hernia Repair clinical study evaluating the performa...
Themefolio
Profiler
Peergroup
© BusinessWire
04.09.2025
ISIN: US81684M1045
Semler Scientific Inc
SMLR
LISTED
NASDAQ
Deadline Approaching: Semler Scientific Inc. (SMLR) Investors Who Lost Money Urged To Contact Law Offices of Howard G. Smith
Article
News Preview
Law Offices of Howard G. Smith reminds investors of the upcoming October 28, 2025 deadline to file a lead plaintiff motion in the case filed on behalf of investors who purchased Semler Scientific Inc. (“Semler” or the “Company”) (NASDAQ: SMLR) securities between March 10, 2021 and April 15, 2025, inclusive (the “Class Period”). IF YOU ARE AN INV...
Themefolio
Profiler
Peergroup
© BusinessWire
04.09.2025
ISIN: US53216B1044
LifeMD, Inc.
LFMD
LISTED
NASDAQ
Deadline Approaching: LifeMD, Inc. (LFMD) Investors Who Lost Money Urged To Contact Law Offices of Howard G. Smith
Article
News Preview
Law Offices of Howard G. Smith reminds investors of the upcoming October 27, 2025 deadline to file a lead plaintiff motion in the case filed on behalf of investors who purchased LifeMD, Inc. (“LifeMD” or the “Company”) (NASDAQ: LFMD) securities between May 7, 2025 and August 5, 2025, inclusive (the “Class Period”). IF YOU ARE AN INVESTOR WHO SUF...
Themefolio
Profiler
Peergroup
© PR Newswire
04.09.2025
ISIN: US81684M1045
Semler Scientific Inc
SMLR
LISTED
NASDAQ
SMLR INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Semler Scientific, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
Article
News Preview
NEW YORK, Sept. 4, 2025 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Semler Scientific, Inc. ("Semler Scientific" or "the Company") (NASDAQ: SMLR) and certain of its officers....
Themefolio
Profiler
Peergroup
© PR Newswire
04.09.2025
ISIN: US6404911066
Neogen Corp
NEOG
LISTED
NASDAQ
Neogen Corporation (NEOG) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
Article
News Preview
Shareholders with losses of $100,000 or more are encouraged to contact the firm. BENSALEM, Pa., Sept. 4, 2025 /PRNewswire/ -- The Law Offices of Howard G. Smith announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against Neogen Corporation ("Neogen" or the "Company") (NASDAQ: NEOG)....
Themefolio
Profiler
Peergroup
© PR Newswire
04.09.2025
ISIN: US53216B1044
LifeMD, Inc.
LFMD
LISTED
NASDAQ
Berger Montague PC Investigates Securities Claims Against LifeMD, Inc. (NASDAQ: LFMD)
Article
News Preview
PHILADELPHIA, Sept. 4, 2025 /PRNewswire/ -- Berger Montague PC, national plaintiffs' law firm, announces a class action lawsuit against LifeMD, Inc. (NASDAQ: LFMD) ("LifeMD" or the "Company") on behalf of investors who purchased or acquired shares during the period from May 7, 2025 through August 5, 2025 (the "Class Period")....
Themefolio
Profiler
Peergroup
© PR Newswire
04.09.2025
ISIN: US14149Y1082
Cardinal Health Inc
CAH
LISTED
NYSE
Cardinal Health at-Home Solutions opens Texas distribution center; announces plans for new California site
Article
News Preview
DUBLIN, Ohio, Sept. 4, 2025 /PRNewswire/ -- Cardinal Health (NYSE: CAH) announced the opening of its newest distribution center in Fort Worth, Texas – a facility solely dedicated to the at-Home Solutions business, a leading medical supplies provider that serves more than 6 million people annually in the United States. In addition, Cardinal Health...
Themefolio
Profiler
Peergroup
© BusinessWire
04.09.2025
ISIN: CA60255C8850
Mind Medicine (MindMed) Inc
MNMD
LISTED
NASDAQ
Journal of the American Medical Association (JAMA) Publishes Results from First-Ever Randomized, Placebo-Controlled Clinical Trial Assessing the Dose-Dependent Efficacy of MM120 (Lysergide D-Tartrate, LSD) in Generalized Anxiety Disorder (GAD)
Article
News Preview
Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (the "Company" or "MindMed"), a late-stage clinical biopharmaceutical company developing novel product candidates to treat brain health disorders, today announced that JAMA has published full results from the Company’s positive Phase 2b study of MM120 (lysergide D-tartrate, LSD) in 198 adults with moder...
Themefolio
Profiler
Peergroup
© PR Newswire
04.09.2025
ISIN: US30161Q1040
Exelixis Inc
EXEL
LISTED
NASDAQ
EXEL Investors Have Opportunity to Join Exelixis, Inc. Fraud Investigation with the Schall Law Firm
Article
News Preview
LOS ANGELES, Sept. 4, 2025 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Exelixis, Inc. ("Exelixis" or "the Company") (NASDAQ: EXEL) for violations of the securities laws....
Themefolio
Profiler
Peergroup
© ACCESSWIRE
04.09.2025
ISIN: US18507C1036
Clearpoint Neuro Inc
CLPT
LISTED
NASDAQ
ClearPoint Neuro Announces FDA Clearance Expanding Compatibility of the ClearPoint Prism Neuro Laser Therapy System with 1.5T MRI Scanners
Article
News Preview
SOLANA BEACH, CALIFORNIA / ACCESS Newswire / September 4, 2025 / ClearPoint Neuro, Inc. (NASDAQ:CLPT) (the "Company"), a global device, cell, and gene therapy-enabling company offering precise navigation to the brain and spine, today announced that the ClearPoint Prism® Neuro Laser Therapy System ("ClearPoint Prism") receiv...
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
Indices
DAX, DOW, S&P, FTSE...
Realtime Trading
With & without leverage
Currencies
EUR, USD, JPY, BRL, GBP ....
50 FX-Pairs
Top Conditions, Tied spreads, Mini/Micro
Commodities
Brent, WTI, Coffee, Wheat....
Long & Short
Crude oil, Agricultural & more
Metals
Gold, Silver, Palladium, Platinum
Hedging
Soft-,Heavy-, Precious Metals
Stocks & ETF
TSLA, NFLX, NVDA, MSFT, AAPL ....
Leveraged Equity Trading
USA, Europe, Asia
More information, click here

More sector specific news

Your Press Release is missing or you want share news over GICS11? Drop us a line.

Gamechanger in online marketing · Innovation as a service · Upgrade your own internet presence.

XLB
XLE
XLU
XLY
XLF
XLP
XLV
XLK
XLC
XLI
XLRE
© 2025 Select Sector SPDRs
* * *
More Sector related Investment Ideas
XLB
XLE
XLU
XLY
XLF
XLP
XLV
XLK
XLC
XLI
XLRE
© 2025 WEBs Investments ETFs
About the newsfeed
#1
What types of information are provided on this portal - and what purpose does it serve?
The portal provides structured, stock market-relevant company information that is specifically assigned to a particular economic sector. The focus is on current announcements from official NewsWire sources, supplemented by company profiles, filter options by sector and sector-specific research aids. The aim is to offer an interested group of people a systematically structured research environment that improves their understanding of sector developments and corporate strategies.
#2
Why are companies categorized according to a certain system?
Financial markets consist of thousands of listed companies with very different business models. In order to create transparency and comparability, companies worldwide are assigned to standardized classifications. These classifications help investors to better analyze markets, identify sector-specific trends and make more targeted investment decisions.
#3
What classification standards exist for grouping companies?
There are various industry classifications that are used depending on the region or application. The best known include GICS (Global Industry Classification Standard), ICB (Industry Classification Benchmark), NAICS (North American Industry Classification System) and TRBC (Thomson Reuters Business Classification). Most institutional investors and ETFs worldwide use GICS or ICB as a benchmark.
#4
What classification standard is this financial information portal based on?
The portal uses the Global Industry Classification Standard (GICS), which was jointly developed by MSCI and S&P Dow Jones Indices. GICS is widely used in the institutional financial world and forms the basis for many global equity indices, ETFs and research systems.
#5
What exactly does GICS mean - and how is the system structured?
GICS stands for Global Industry Classification Standard. It is a hierarchical structure that divides listed companies worldwide into four levels: Sector, Industry Group, Industry Sector and Sub-Industry. In total, the system comprises 11 main sectors, over 60 industries and more than 150 sub-categories. It allows a consistent, internationally comparable analysis of economic activities.
#6
Why is GICS important in the financial world?
GICS offers a standardized language for investment decisions. It makes it possible to compare companies with similar business models - regardless of country, stock exchange or company size. Many investment funds, indices and research houses use GICS as a basis for portfolio construction, risk analysis or market screening. This means that it also makes sense for private investors to use this structure as a guide.
#7
Who decides which GICS sector a company is assigned to?
The allocation is made by the index providers MSCI and S&P Dow Jones on the basis of a company's main business segment. The decisive factor is the segment from which the company generates the majority of its sales or operating profit. Changes in the business model or strategic realignments can lead to a company being assigned to a different industry or even a different sector.
#8
What is meant by the GICS sector "Materials"?

The GICS "Materials" sector comprises companies that are active in the production, processing or refinement of raw materials. This includes industries such as chemicals, building materials, paper & forest products and the entire metallurgical and mining industry. The sector is highly cyclical and is particularly sensitive to economic fluctuations and changes in global demand.

#9
Which companies typically belong to the Materials sector?
Typical representatives are international groups from the areas of chemicals production (e.g. BASF), precious metal mining (e.g. Barrick Gold), building materials production (e.g. Heidelberg Materials) or industrial gases (e.g. Linde). The shares of these companies are often heavily dependent on commodity prices and play a central role in industrial value chains.
#10
Where does the company news on this page come from?
The news is based on verified and publicly available sources such as BusinessWire, GlobeNewswire, PR Newswire, EQS, Newsfile, ACCESSNewswire and other NewsWire services. These platforms are used by listed companies to publish mandatory ad hoc announcements, financial reports or strategic developments. All content is prepared in a structured manner and, if a corresponding categorization is possible, brought together in industry-specific clusters.
#11
How is the sector-specific mapping of messages carried out?
Categorization is based on structured metadata (e.g. ISIN, ticker, sector classification) and a combination of keyword analysis and GICS mapping. This ensures that all news is assigned to the correct sector and - if available - the correct sub-sector.
#12
Why is the materials sector particularly interesting for investors?
The Materials sector is closely linked to global industrial production and offers both cyclical growth opportunities and hedging opportunities against inflation and raw material shortages. In addition, many companies in this sector play a key role in future topics such as electromobility, the energy transition and sustainable building materials.
#13
What distinguishes this project from traditional financial information portals?
In contrast to generic portals, this project focuses exclusively and specifically on a particular sector. The advantage for interested investors: Sector-specific information, news, market movements and company profiles can be filtered and analyzed in a more targeted manner. This enables more in-depth research and greater relevance for thematic investment decisions.
#14
Are smaller companies also represented here or only large corporations?
The newsfeed takes into account both large caps and mid and small caps. As a clear mapping criterion is required in order to enable the most precise possible allocation to a cluster, the ISIN of the listed company is generally used for this purpose, provided that this can be made available or mapped via corresponding newsfeed parameters.
#15
How up-to-date are the displayed messages?
The content is updated regularly. The publication follows the publications of the information source, the NewsWire feeds of the underlying distributors. Incoming reports are automatically processed, classified and displayed on the page. Timestamps and source information ensure maximum transparency.
#16
Can I also filter the news by sub-sector?
Yes, this is a central feature of the site. Within a main sector, you can filter specifically for sub-sectors such as "Metals & Mining". For particularly popular industries or developments within a meta-sector, it is possible to deviate from standard clusters. Special categories with particular information value enable thematic analyses to be carried out even more precisely.
#17
Are there plans to process other metasectors in a similar way?
Yes, this financial information portal is part of an extensive project in which separate information portals are being created for all the main sectors. The aim is to provide investors with a systematic, sector-based research tool - regardless of index affiliation or provider perspective.
#18
Why do companies publish announcements via NewsWire services at all?
NewsWire services such as BusinessWire or PR Newswire fulfill a regulatory function: they enable companies to publish price-sensitive information publicly and without discrimination. In many countries, the use of such services is a prerequisite for fulfilling publication obligations under capital market law. They also enable companies to reach the media, analysts and investors in a targeted manner.
#19
Can private or inactive companies also appear in such notifications?
Generally not. The platform focuses exclusively on listed companies whose disclosures are based on regulatory requirements or corporate strategy measures. Although private or unlisted companies occasionally publish announcements, these are not systematically processed or classified here.
#20
What happens when a company changes its business model - does its sector classification also change?
Yes, as a rule - but not automatically. The responsible classification institutes (e.g. MSCI and S&P for GICS) regularly check the relevance and consistency of the classifications. If there is a significant change in a company's sales or profit profile, it may be reclassified to a different industry or even a different sector. This usually takes place after fixed review cycles or upon request.
#21
How is it ensured that a company is correctly categorized if it is active in several business areas?
The categorization is based on the dominant sales segment. If a company is active in several sectors but generates 70% of its turnover with chemical products, for example, it is assigned to the GICS sector "Materials" - even if it also has activities in the energy or transportation sector. In borderline cases, additional qualitative assessment criteria apply.
#22
Are there any legal risks in the further use of the displayed content?
The content comes from public sources, but is partially subject to copyright protection - particularly with regard to text structure and layout. The excerpts and links provided on this portal are made within the scope of permitted use (e.g. right to quote or editorial processing). However, commercial use by third parties is not permitted without the express permission of the original providers.
#23
Who can I contact if I have general questions or legal concerns?
A central contact point is available for general inquiries, information on company recordings, compliance issues or copyright-relevant aspects. In rare cases, for example in the case of erroneously published information or justified requests for deletion, a review and, if necessary, removal from the public feed can take place. Please only use the official contact option in the legal notice or at the bottom of the page.
#24
Is advertising or third-party content also displayed on the portal?
Yes, in defined areas the portal can display advertising content or product-specific information from third parties - for example on sector-related financial services, research offers or trading platforms. This content is clearly marked as advertising or partner information and is separate from the editorial or automatically processed company news.
#26
Can I give feedback on the platform or submit suggestions?
Absolutely - feedback is expressly welcome. The platform is an open information service that is continuously being developed. Comments on functionality, data quality, usability or thematic extensions help to optimize the service for the benefit of users. You can submit your suggestions informally via the contact page or special feedback forms.
#27
I am an information provider - can I cooperate with the portal?
Yes, the portal is open to content-related, technical or editorial cooperation, provided that this contributes to the quality, relevance or dissemination of the offering. If you offer content, interfaces or services that could be useful in the context of stock market-related information, we would be pleased to hear from you. The platform offers flexible integration options and a professional environment for quality-assured content.
#28
Can the platform technology also be used for other applications or partners?
Yes, the platform is based on a modular, scalable infrastructure that can be adapted to different information contexts and industry models. Technical components such as data aggregation, structuring logic, classification mechanisms and semantic filters can also be made available for external projects or individual applications on request. Please contact us for cooperation or license models.
#29
Can the underlying company data also be licensed or reused?
Structured access to selected master data of listed companies - such as GICS mapping, ISIN mapping, news feeds or metadata filters - is generally possible. The offer is aimed in particular at information service providers, research platforms or data-driven financial applications. Data can be provided via defined interfaces (e.g. API) or exportable formats, depending on the intended use and license framework.
#30
What forms of cooperation with external partners are conceivable?
Basically open. Possible forms of cooperation range from technical integrations and shared data models to content syndication or white label solutions. Partnerships with institutions that are looking for access to quality-assured data, dynamically structured news or sector-specific analyses - for example in the FinTech, media or research environment - are particularly interesting. We look forward to hearing from business development or product management departments.
#31
Why does this portal differ technically and conceptually from other information offerings?
Because no one from outside the industry is trying to understand the financial market here - but because the know-how comes from the heart of the financial world. The technical platform was developed by a team that combines in-depth market knowledge with innovative system design. The result: information architecture with real relevance, not shop window technology.
#32
What makes the technical solution particularly interesting for operators of their own financial portals?
In addition to high adaptability, the platform impresses with its modular structure and the consistent implementation of industry-specific logic - from GICS mapping to metadata filtering. For providers who operate their own information portals, sector-specific data structures, news feeds or visualizations can be quickly integrated on this basis - either as a white label, API module or embedded solution.
#33
Why can a collaboration go beyond traditional development services?
Because we don't just program, we think: The technological implementation is based on a deep understanding of market cycles, regulations, data formats and investor needs. Anyone who cooperates with this platform benefits from a sparring partner at eye level - both technically and professionally. This creates added value that goes far beyond pure IT expertise.
#34
Note on copyright and the processing of original content
The corporate news presented on this information portal is based on publicly accessible sources such as BusinessWire, GlobeNewswire, PR Newswire or comparable news services. The content is processed as part of an automated or editorially supported structuring process without changing, shortening or reinterpreting the content of the original information. This is so-called "as is" information, the form and content of which corresponds to the originally published announcement. The rights to the original texts remain unrestrictedly with the respective publishers or copyright holders. This portal merely assumes a structural categorization and allocation within the framework of a news-journalistic offer. Independent commercial reuse, systematic reproduction or other use of the content by third parties is only permitted within the framework of the statutory provisions or with the consent of the copyright holder.
About GICS Health
GICS Health is part of the GICS Eleven information portfolio, which focuses primarily on information from listed companies in the health sector. The sector classification serves as a guide to navigate quickly and conveniently through the latest industry-specific news. Individual peer group clusters complement the news offering.
About GICS Eleven

GICS Eleven (G11, GICS11) bundles topic-specific content and enables quick access to relevant information thanks to its gate function. The project is largely based on the Global Industry Classification Standard (GICS®), which was developed by MSCI and Standard & Poor's and enables a breakdown into sectors. GICS® consists of 11 sectors, 24 industry branches, 69 industries and 158 sub-industries.

GICS® is a registered trademark of MSCI Inc. and S&P Dow Jones Indices.

Member of 3R/RSQ Network
Digital Content
Network Alliance
Transparency - Reliability - Credibility
Information regarding Product Information
Monday, 17.11.2025, Calendar Week 47, 321st day of the year, 44 days remaining until EoY.